Recombinant Human BGN Protein, Sia-Increased Human Cell Lines (CAT#: GLJF-0622-JF376)

Product Overview	Recombinant human BGN protein (NP_001702.1) is produced in Sia-Increased Human Cell Lines. This expression system is used for the production of glycoproteins with high sialylation and core fucosylation.
Source	Sia-Increased Human Cell Lines
Species	Human
Tag	His-tag, FC-tag
Purity	>90%, determined by SDS-PAGE.
Endotoxin Level	Regular batch
Conjugation	None

Target	BGN
Full Name	Biglycan
Gene ID	633
Uniprot ID	P21810
Accession Number	NP_001702.1
Background	This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication.
Alternate Names	Bone/cartilage proteoglycan I; PG-S1; BGN; SLRR1A